Decrement in Operant Performance Produced by NMDA Receptor Antagonists in the Rat: Tolerance and Crosstolerance

详细信息    查看全文

• 作者：Dravolina ; Olga A. ; Zvartau ; Edwin E. ; Bespalov ; Anton Y.
• 关键词：Dizocilpine (MK-801) ; Memantine ; d-CPPen (SDZ EAA 494) ; ACEA-1021 ; Eliprodil ; Operant behavior ; Tolerance ; Rats
• 刊名：Pharmacology Biochemistry and Behavior
• 出版年：2000
• 出版时间：April, 2000
• 年：2000
• 卷：65
• 期：4
• 页码：611-620
• 全文大小：520 K

文摘

Current perspectives on the clinical use of NMDA receptor antagonists infer repeated administration schedules for the management of different pathological states. The development of tolerance and crosstolerance between different NMDA receptor antagonists may be an important factor contributing to the clinical efficacy of these drugs. The present study aimed to characterize the development of tolerance and crosstolerance to the ability of various site-selective NMDA receptor antagonists to produce a decrement of operant responding (multiple extinction 9 s fixed-interval 1-s schedule of water reinforcement). Acute administration of -CPPen (SDZ EAA 494; 1–5.6 mg/kg), dizocilpine (MK-801; 0.03–0.3 mg/kg), memantine (0.3–17 mg/kg), ACEA-1021 (10–56 mg/kg), and eliprodil (1–30 mg/kg) differentially affected operant responding. Both increases and decreases in response rates and accuracy of responding were observed. Repeated preexposure to -CPPen (5.6 mg/kg, once a day for 7 days) attenuated a behavioral disruption produced by an acute challenge with -CPPen or ACEA-1021, but potentiated the effects of dizocilpine, memantine, and eliprodil. Based on the present results, one can suggest that the repeated administration of a competitive NMDA receptor antagonist differentially affects the functional activity of various sites on NMDA receptor complex.